DATA FORM FOR CANCER STAGING - CORPUS UTERI (ENDOMETRIUM)
Form # 785-1-039
| CLIN | PATH | TNM FIGO* DEFINITIONS | |||
| CATERGORY STAGE PRIMARY TUMOR (T) | |||||
| TX | Primary tumor cannot be assessed | ||||
| T0 | No evidence of primary tumor | ||||
| Tis | Carcinoma in situ | ||||
| T1 | I | Tumor confined to corpus uteri | |||
| T1a | IA | Tumor limited to endometrium | |||
| T1b | IB | Tumor invades up to or less than one half of the myometrium | |||
| T1c | IC | Tumor invades to more than one half of the myometrium | |||
| T2 | II | Tumor invades cervix but does not extend beyond uterus | |||
| T2a | IIA | Endocervical glandular involvement only | |||
| T2b | IIB | Cervical stromal invasion | |||
| T3 | III | Local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B and C below &/or N1 | |||
| T3a | IIIA | Tumor involves serosa and/or adnexae (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings | |||
| T3b | IIIB | Vaginal involvement (direct extension of metastasis) | |||
| N1 | IIIC | Metastasis to the pelvic and /or paraaortic lymph nodes | |||
| T4** | IVA | Tumor invades bladder mucosa and/or bowel mucosa | |||
| M1 | IVB | Distant metastasis (Excluding metastasis to vagina, pelvic serosa or adnexae. Including metastasis to intraabdominal lymph nodes other than paraaortic, and/or inguinal lymph nodes.) | |||
| LYMPH NODE (N) | |||||
| NX | Regional lymph nodes cannot be assessed | ||||
| N0 | No regional lymph node metastasis | ||||
| N1 | Regional lymph node metastasis | ||||
| DISTANT METASTASIS (M) | |||||
| MX | Presence of distant metastasis cannot be assessed | ||||
| M0 | No distant metastasis | ||||
| M1 | Distant metastasis | ||||
*FIGO: Federation Internationale de Gynecologie et d'Obstetrique **Note: presence of bullous edema is not sufficient evidence to classify a tumor T4.
| CLIN | PATH | STAGE GROUPING | ||||
| AJCC/UICC FIGO | ||||||
| 0 | Tis | N0 | M0 | |||
| IA | T1a | N0 | M0 | Stage IA | ||
| IB | T1b | N0 | M0 | Stage IB | ||
| IC | T1c | N0 | M0 | Stage IC | ||
| IIA | T2a | N0 | M0 | Stage IIA | ||
| IIB | T2b | N0 | M0 | Stage IIB | ||
| IIIA | T3a | N0 | M0 | Stage IIIA | ||
| IIIB | T3b | N0 | M0 | Stage IIIB | ||
| IIIC | T1 | N1 | M0 | Stage IIIC | ||
| T2 | N1 | M0 | ||||
| T3a | N1 | M0 | ||||
| T3b | N1 | M0 | ||||
| IVA | T4 | Any N | M0 | Stage IVA | ||
| IVB | Any T | Any N | M1 | Stage IVB | ||
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| Comments: |
| Patient Name: |